Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TSE:2892
TSE:2892Food

Nihon Shokuhin Kako (TSE:2892) Quarterly Loss And 1.9% Margin Undermine Bullish Narratives

Nihon Shokuhin Kako (TSE:2892) reported a mixed Q3 2026 update, with revenue of ¥14.4b and a net loss of ¥236m, translating to basic EPS of ¥48.12, while trailing twelve month EPS was ¥238.69. Over recent quarters the company’s revenue has ranged between ¥14.4b and ¥17.2b, with quarterly basic EPS between ¥10.98 and ¥154.34 as results moved from profits to the latest quarterly loss. This highlights a backdrop of modest revenue changes alongside tighter margins and more fragile earnings...
OTCPK:BFCC
OTCPK:BFCCBanks

BankFirst Capital (OTCPK:BFCC) EPS Strength Reinforces Steady Growth Narrative

BankFirst Capital (BFCC) closed out FY 2025 with fourth quarter total revenue of US$37.5 million and basic EPS of US$1.74, alongside net income of US$10.2 million, setting a clear reference point for the year’s performance. Over recent quarters, revenue has ranged from US$27.9 million to US$37.5 million while quarterly EPS moved between US$0.83 and US$1.74. This gives investors a tangible sense of how the top line and per share earnings have tracked through the year. With trailing 12 month...
NYSE:WAT
NYSE:WATLife Sciences

Is Waters (WAT) Pricing Look Justified After Recent Share Price Weakness?

If you are wondering whether Waters at around US$370 per share is offering fair value right now, it helps to step back and look at what the current price is really reflecting. The stock is down about 5.5% over the past week, 2.9% over the last month and 10.8% over the past year. The 3 year and 5 year returns sit at 8.6% and 30.8% respectively. Recent coverage has focused on how established life sciences companies like Waters are being reassessed by investors as they weigh up long term demand...
NYSE:AN
NYSE:ANSpecialty Retail

Assessing AutoNation (AN) Valuation After Recent Share Price Pullback And Long Term Gains

Why AutoNation is on investors’ radar today AutoNation (AN) is drawing attention after recent trading left the stock with mixed short term performance, including a 1 day decline and weaker past week returns compared with the past 3 months. With the share price around $204.98 at the last close, investors are weighing that performance against AutoNation’s reported revenue of about $27.9b and net income of roughly $663.1m, along with its longer term total returns. See our latest analysis for...
TSE:7276
TSE:7276Auto Components

Koito Manufacturing Q3 One Off Gain Clouds Earnings Momentum Narratives

Koito Manufacturing (TSE:7276) has put up a busy Q3 2026 scorecard, with revenue at ¥243.2b and basic EPS of ¥41.72, set against a trailing twelve month EPS base of ¥143.54 and net income of ¥40.1b. The company has seen quarterly revenue move from ¥231.1b in Q3 2025 to ¥243.2b in Q3 2026, while basic EPS shifted from ¥61.47 to ¥41.72 over the same stretch, giving investors a clear line of sight on how the top and bottom lines are tracking into this year. With net margin running at 4.3% on a...
TSE:4658
TSE:4658Commercial Services

Nippon Air Conditioning Services (TSE:4658) Margin Improvement Reinforces Bullish Earnings Narratives

Nippon Air Conditioning Services (TSE:4658) has posted its Q3 2026 numbers, reporting revenue of ¥17.3b and basic EPS of ¥15.65, alongside trailing twelve month EPS of ¥97.70. The company recorded revenue of ¥17.3b in both Q3 2025 and Q3 2026, while quarterly basic EPS moved from ¥19.26 to ¥15.65. Over the last year, the trailing net profit margin was 5% compared with 4.6% in the prior year. Together, the latest quarter and the trailing profitability profile provide investors with a clearer...
NYSE:MPT
NYSE:MPTHealth Care REITs

A Look At Medical Properties Trust (MPW) Valuation As Options Activity Climbs Before Earnings

Medical Properties Trust (MPW) is back on traders’ radar after a surge in call options activity and higher implied volatility ahead of its February 26 earnings release, which points to heightened expectations around the upcoming numbers. See our latest analysis for Medical Properties Trust. At a share price of US$5.02, Medical Properties Trust has seen relatively muted recent share price returns. Its 1 year total shareholder return of 14.29% contrasts with much weaker 3 and 5 year total...
NasdaqGM:QCRH
NasdaqGM:QCRHBanks

Will Record 2025 Earnings and Wealth Management Growth Change QCR Holdings' (QCRH) Narrative

QCR Holdings, Inc. recently reported full-year 2025 results, with net interest income rising to US$255.22 million and net income reaching US$127.19 million, alongside higher basic and diluted earnings per share from continuing operations versus 2024. Beyond record profitability, the bank expanded its wealth management franchise with nearly 500 new client relationships and over US$1 billion of new assets under management, while also selling US$285 million of LIHTC construction loans that...
NYSE:HP
NYSE:HPEnergy Services

The Bull Case For Helmerich & Payne (HP) Could Change Following CEO Shift And Saudi Rig Reactivations

Helmerich & Payne recently announced a leadership transition with CEO John W. Lindsay stepping down and President Trey Adams taking over, alongside plans to reactivate seven idle drilling rigs in Saudi Arabia through the first half of 2026 and a measured stance on potential opportunities in Venezuela. This combination of new leadership and renewed international rig activity signals a meaningful shift in how the company may approach growth and geographic risk. We’ll now examine how the...
OM:CAST
OM:CASTReal Estate

How Castellum’s Infinity Hagastaden Lease and UBS Backing May Shape Castellum (OM:CAST) Investors

In late January 2026, Castellum announced a 15-year lease for approximately 24,000 square metres at its Infinity project in Hagastaden, Stockholm, with construction having started in autumn 2025 and completion targeted for late 2027, while the unnamed tenant retains an option to halve the space and shorten the term by mid-2026. On the same day, UBS issued an upbeat research view on Castellum’s repositioning under CEO Pål Ahlsén, highlighting portfolio reshaping efforts and an ambition to...
ASX:ILU
ASX:ILUMetals and Mining

A Look At Iluka Resources (ASX:ILU) Valuation After Impairment Charges And Production Suspension

Iluka Resources (ASX:ILU) has drawn fresh attention after flagging about A$565 million in impairment and inventory charges, suspending output at its Cataby mine and synthetic rutile kiln, and outlining cost cutting alongside rare earths investment. See our latest analysis for Iluka Resources. Those announcements have come on top of existing pressure, with a 1-day share price return of a 3.42% decline and a 7-day share price return of a 22.99% decline, even though the 1-year total shareholder...
NYSE:FICO
NYSE:FICOSoftware

Assessing Fair Isaac (FICO) Valuation After Another Earnings Beat And Record Scores Growth

How the latest earnings beat is shaping the Fair Isaac (FICO) story Fair Isaac (FICO) has just delivered another quarter where revenue and earnings topped analyst expectations, with both the Scores and Software segments contributing to year over year growth. That mix of outperformance, record Scores revenue and strong software ACV bookings, supported by new scoring models and partnerships, is what has pushed Fair Isaac back onto many investors’ radar. See our latest analysis for Fair...
ENXTPA:SGO
ENXTPA:SGOBuilding

Saint Gobain ESG Focus At Life Sciences Site And Investor Takeaways

Saint-Gobain recently highlighted employee empowerment and sustainability commitments at its Life Sciences facility. The update focuses on workforce development, environmental initiatives and how these support the group’s broader ESG ambitions. The news adds fresh context for investors following Compagnie de Saint-Gobain (ENXTPA:SGO), currently trading at around €83.22. For investors watching ENXTPA:SGO, this spotlight on the Life Sciences facility comes alongside a mixed share price...
OTCPK:CMRB
OTCPK:CMRBBanks

Fourth Quarter Net Interest Margin Gain At First Commerce Bancorp (OTCPK:CMRB) Challenges Cost Concerns

First Commerce Bancorp (CMRB) has wrapped up FY 2025 with fourth quarter revenue of US$13.0 million and basic EPS of US$0.16, capping off a year where trailing twelve month revenue reached US$43.7 million and EPS came in at US$0.41. The company has seen revenue move from US$34.7 million to US$43.7 million on a trailing basis, while EPS shifted from US$0.21 to US$0.41 over the same period. This sets the stage for investors to focus on how margins and earnings quality shape the story from...
CPSE:SCHO
CPSE:SCHOFood

Will Schouw & Co.'s 2026 Revenue Guidance Shape Aktieselskabet Schouw's (CPSE:SCHO) Investment Narrative?

In late January 2026, Aktieselskabet Schouw & Co. issued consolidated revenue guidance for 2026, forecasting between DKK 33,000 million and DKK 35,500 million. This guidance provides investors with a clearer view of the company’s expected scale of operations and potential demand across its portfolio businesses. We’ll now examine how this 2026 revenue outlook sharpens Aktieselskabet Schouw’s investment narrative and what it may imply for future positioning. Trump has pledged to "unleash"...
OM:SECT B
OM:SECT BHealthcare Services

How Investors May Respond To Sectra (OM:SECT B) Winning Expanded Imaging Contract At Major German Hospital

TUM Klinikum Rechts der Isar in Germany has expanded its use of Sectra’s enterprise imaging solution, signing a five-year contract in Sectra’s fiscal Q3 2025/2026 to add pathology and ophthalmology modules licensed for up to 300,000 examinations per year. This extension underscores how Sectra’s unified imaging platform is being adopted across additional clinical disciplines to support efficiency, collaboration, and lower operational costs in large hospital settings. Next, we will examine how...
NasdaqGS:LITE
NasdaqGS:LITECommunications

New Lumentum 2x ETF Fuels Volatility Around Cloud And AI Demand

A new 2x leveraged single stock ETF tied to Lumentum Holdings (NasdaqGS:LITE) has launched, targeting traders who want amplified exposure to the company. The product is linked to short term price moves in Lumentum, and its debut has coincided with higher trading volumes and more visible intraday swings. The ETF centers investor attention on Lumentum’s role in cloud and networking demand, particularly around optical and photonic components used in data infrastructure. Lumentum Holdings,...
NYSE:DOLE
NYSE:DOLEFood

Assessing Dole (DOLE) Valuation After Earnings Beat Buyback Approval And Dividend Support

Why Dole’s latest quarter matters for investors Dole (NYSE:DOLE) recently reported quarterly revenue ahead of forecasts, putting a spotlight on its operational control, cost discipline, and vertically integrated produce network at a time when tariffs and input costs remain key watchpoints. See our latest analysis for Dole. The latest quarterly beat arrives after a period of steady momentum, with a 90 day share price return of 25.24% and a 1 year total shareholder return of 19.76%. This hints...
TSE:4220
TSE:4220Chemicals

Riken Technos (TSE:4220) One Off Gain Lifts Margins And Tests Bullish Earnings Narratives

Riken Technos (TSE:4220) has put up a solid set of headline numbers for Q3 2026, with revenue of ¥33.7b and basic EPS of ¥52.67, backed by quarterly net income of ¥2.5b. The company has seen revenue move from ¥32.0b in Q2 2025 to ¥33.7b in Q3 2026, while quarterly basic EPS has ranged from ¥13.79 to ¥52.67 over that period, giving investors a clear view of how the top line and per share earnings have been tracking through recent quarters. With trailing net margin sitting at 6.3% versus 5% a...
XTRA:NEM
XTRA:NEMSoftware

Nemetschek’s AI-Focused Acquisitions and Record 2025 Revenue Might Change The Case For Investing In Nemetschek (XTRA:NEM)

Nemetschek Group has reported past fiscal 2025 results that exceeded its already raised revenue and profitability targets, with currency-adjusted growth of 22.6% and annual revenue surpassing €1.00 billion for the first time. By coupling this record performance with AI-focused innovations and acquisitions such as Firmus AI, Nemetschek is reinforcing its role in the digitalization of the construction industry. Next, we’ll examine how Nemetschek’s AI-driven expansion and record revenue...
NYSE:EVR
NYSE:EVRCapital Markets

Evercore Survey Underscores Rising Private Credit Secondaries And Fee Potential

Evercore (NYSE:EVR) released its 2025 Credit Secondary Market Survey, highlighting record activity in private credit secondaries. The survey points to GP led deals surpassing LP led transactions, indicating a shift in how capital is being recycled in private credit. Evercore reported a significant advisory role in this market, capturing a substantial share of recent deal volume. For you as an investor looking at Evercore at a share price of $353.27, this survey matters because it highlights...